Novavax applies to WHO for emergency listing of COVID-19 vaccine - Reuters

lailaikamu.blogspot.com

A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration

Sept 23 (Reuters) - Novavax Inc (NVAX.O) and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax's COVID-19 vaccine, the company said on Thursday.

The WHO's emergency use listing is a signal to national regulatory authorities on a product's safety and efficacy.

It is also a prerequisite for export to several countries participating in the COVAX vaccine sharing facility.

Novavax has said it would focus on low- and middle-income countries for initial supplies of the vaccine, as the United States and other Western nations have already vaccinated a large part of their populations with other vaccines.

Novavax had previously said it would apply for the listing in August, marking a slight delay in the filing.

Novavax and Serum Institute, the world's largest vaccine producer, have committed to together provide more than 1.1 billion doses to the COVAX facility, which aims to provide equitable access to COVID-19 vaccines to low- and middle-income countries.

The Novavax shot is a protein-based vaccine, and was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based clinical trial.

Reporting by Manas Mishra and Leroy Leo in Bengaluru; Editing by Maju Samuel and Sriraj Kalluvila

Our Standards: The Thomson Reuters Trust Principles.

Adblock test (Why?)

"who" - Google News
September 23, 2021 at 09:05PM
https://ift.tt/3CzpDOO

Novavax applies to WHO for emergency listing of COVID-19 vaccine - Reuters
"who" - Google News
https://ift.tt/36dvnyn
https://ift.tt/35spnC7

Bagikan Berita Ini